. 2017 May 19;37(3):BSR20170150. doi: 10.1042/BSR20170150

Table 4. Subpopulation proportions delineated by FSC/Vt (central) and FSC/Vt (extended) strategies in normal pregnancy and URM.

Marker	Cell	FSC/Vt (central)		FSC/Vt(extend)
		Normal pregnancy	URM	Normal pregnancy	URM
CD3⁺CD56^–	T	25.4 ± 2.6	25.5 ± 2.9	19.5 ± 2.1	21.8 ± 2.8
CD3^–CD56^brightCD16^–	dNK	41.9 ± 4.2	48.3 ± 4.0	45.0 ± 3.4	49.6 ± 3.8
CD3^–CD56^brightCD16^–/ CD3⁺CD56^–	dNK/T	1.5 ± 0.1	2.0 ± 0.4	2.2 ± 0.1	2.2 ± 0.1
CD3⁺CD56⁺	NKT-like	7.4 ± 1.1	6.1 ± 1.4	7.3 ± 0.7	6.1 ± 1.5
CD3⁺CD4⁺CD8^–	Th	55.5 ± 2.0	49.8 ± 5.9	52.6 ± 2.0	47.3 ± 5.9
CD3⁺CD4^–CD8⁺	Tc	27.0 ± 1.5	25.7 ± 1.9	30.2±1.5	26.7 ± 1.9
CD3⁺CD4⁺CD8^–/ CD3⁺CD4^–CD8⁺	Th/Tc	2.1 ± 0.1	2.1 ± 0.2	2 ± 0.2	1.9 ± 0.2
CD3⁺CD4⁺CD8^–IFN-γ⁺IL-4^–	Th1	38.5 ± 2.5	46.8 ± 1.8	35.4 ± 1.9	46.8 ± 1.8
CD3⁺CD4⁺CD8^–IFN-γ^–IL-4⁺	Th2	0.6 ± 0.1	0.5 ± 0.1	0.5 ± 0.1	1.1 ± 0.3
CD3⁺CD4⁺CD8^–IFN-γ⁺IL-4⁺	Th DP^*	2.9 ± 0.5	4.5 ± 1.0	2.2 ± 0.3	6.6 ± 1.2
CD3⁺CD4⁺CD8^–IFN-γ⁺IL-4^– /CD3⁺CD4⁺CD8^–IFN-γ^–IL-4⁺	Th1/Th2	111.8 ± 25.9	133.9 ± 14.7	118.3 ± 25.7	75.5 ± 15.8
CD3⁺CD4^–CD8⁺IFN-γ⁺IL-4^–	Tc1	50.1 ± 2.5	63.5 ± 2.4	44.0 ± 2.6	63.9 ± 2.7
CD3⁺CD4^–CD8+IFN-γ^–IL-4⁺	Tc2	1.5 ± 0.4	0.9 ± 0.3	3.0 ± 0.9	0.9 ± 0.3
CD3⁺CD4^–CD8+IFN-γ⁺IL-4⁺	Tc DP^*	2.4 ± 0.6	2.7 ± 0.6	3.0 ± 0.9	3.3 ± 0.7
CD3⁺CD4⁻CD8+IFN-γ⁺IL-4⁻ /CD3⁺CD4^– CD8+IFN-γ^–IL-4⁺	Tc1/Tc2	134.7 ± 32.4	89.2 ± 9.2	88.9 ±3 7.6	87.0 ± 10.1
CD3^–CD56^brightCD16^–IFN-γ⁺IL-4^–	dNK1	4.3 ± 0.9	9.5 ± 2.5	3.1 ± 0.7	13.0 ± 2.9
CD3^–CD56^brightCD16^–IFN-γ^–IL-4⁺	dNk2	0.7±0.2	1.3±0.4	0.2±0.1	4.7 ± 1.7
CD3^–CD56^brightCD16^–IFN-γ⁺IL-4⁺	dNK DP^*	0	0.1±0.02	0	0.6 ± 0.2
CD3^–CD56^brightCD16^–IFN-γ⁺IL-4^– /CD3^–CD56^brightCD16^–IFN-γ^–IL-4⁺	dNk1/dNK2	25.4 ± 11.4	24.1 ± 13.0	32.0 ± 10.1	7.1 ± 2.4

*DP represents double positive cell.